-
Cancer Death Risk Up for Kidney Transplant, Dialysis Patients
drugs
February 15, 2019
Dialysis and kidney transplant patients have more than a 2.5-fold increased risk for cancer death, according to a study published online Feb. 14 in the Journal of the American Society of Nephrology....
-
New insight into cell receptors opens the way for tailored cancer drugs
worldpharmanews
February 12, 2019
New research on how cancer mutations influence a certain type of receptor on the cell membrane opens the way for the development of tailored drugs for certain cancers, such as rectal cancer and lung cancer.
-
Study suggests aspirin may help some patients survive head and neck cancer
worldpharmanews
January 29, 2019
Regular use of aspirin or other nonsteroidal anti-inflammatory drugs (NSAIDs) may help some patients with head and neck cancer survive the disease...
-
Many New Cancer Patients Unaware of Their Hepatitis Status
drugs
January 23, 2019
A substantial proportion of patients with newly diagnosed cancer and concurrent hepatitis B virus (HBV) or hepatitis C virus (HCV) infection are unaware of their viral infection at the time of cancer diagnosis...
-
US cancer patients trial Proteus’ digital chemotherapy pill
pharmaphorum
January 23, 2019
Cancer patients in the US are trialling digital oncology drugs for the first time, collecting data on patients in a bid to improve outcomes and help adherence.
-
Proteus Digital Health introduces digital medicines for cancer
pharmaceutical-technology
January 21, 2019
In collaboration with Fairview Health Services and University of Minnesota Health in the US, Proteus Digital Health has launched digital medicines to boost outcomes for cancer patients.
-
Nanoparticle breakthrough in the fight against cancer
worldpharmanews
January 21, 2019
A team of researchers, affiliated with UNIST has recently introduced a novel targeted drug delivery system that can improve the pharmacological and therapeutic properties of conventional cancer treatments.
-
Muscle stem cells can drive cancer that arises in Duchenne muscular dystrophy
worldpharmanews
January 16, 2019
People with Duchenne muscular dystrophy (DMD) can develop an otherwise-rare muscle cancer, called rhabdomyosarcoma, due to the muscle cells' continuous work to rebuild the damaged tissue.
-
Liquid biopsy-based system could prevent cancer from spreading
pharmaphorum
January 14, 2019
Angle’s liquid biopsy system has been used in new cancer research that could provide a novel way to treat breast cancer and other tumours, by stopping or suppressing their spread from the original site.
-
UC Berkeley develops drug sponge to soak up chemotherapy side effects
pharmaceutical-technology
January 11, 2019
Chemical engineers at the University of California, Berkeley (UC Berkeley) have developed a drug sponge that could absorb the residual chemotherapy drug and minimise cancer treatment side effects.....